Healthy volunteer.
Conditions
Interventions
Intervention 1: During the intervention, participants in the intervention group will receive one 50,000- IU- Pearl of vitamin D 3 for 8 weeks (every week). Intervention 2: Participants in the control
Treatment - Drugs
During the intervention, participants in the intervention group will receive one 50,000- IU- Pearl of vitamin D 3 for 8 weeks (every week).
Participants in the control group will receive placebo for 8 weeks (every week).
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria Willingness to cooperate in the research project; Healthy; Vitamin D3 serum levels less than 20 nmol per liter; Age 20 to 65 years old Exclusion criteria having infectious diseases and inflammatory disorders of the thyroid gland; Digestive diseases such as stomach ulcers and inflammatory bowel disease; Pregnancy; Chronic use of glucocorticoid drugs, non-steroidal anti-inflammatory drugs, thyroxine, warfarin, D3 supplements; Injection of D3 Vitamin during the last year -Diabetes
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Vitamin D 3 Level. Timepoint: Before and 2 month after the intervention. Method of measurement: HPLC.;Serum Insulin Level. Timepoint: Before and 2 month after the intervention. Method of measurement: CLIA.;Fat Percent of body. Timepoint: Before and 2 month after the intervention. Method of measurement: DXA Lunar. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Osati
Shahid Beheshti University of Medical Sciences.
Outcome results
None listed